26 mai 2022 – On 4 May 2022, the Federal Council adopted the new Ordinance on In Vitro Diagnostic Medical Devices (IvDO) and the amendment to the Ordinance on Clinical Trials with Medical Devices (ClinO-MD). The aim of the new regulations is to improve patient safety by means of stricter requirements for conformity assessment and post-market surveillance. The new legal requirements entered into force on 26 May 2022. Clinical trials with in vitro diagnostic medical devices will be regulated in the Ordinance on Clinical Trials with Medical Devices (ClinO-MD) and no longer in the Ordinance on Clinical Trials (ClinO).

For more information, see here.